PD-L1 positivity defined as ≥ 5% PD-L1 expression on TCs resulted in 23% (22/94) and 34% (33/97) PD-L1+ tumor specimens for the SP142 and 22C3 clone, respectively (Table 1). The gene discussed is CD274; the disease is neoplasm.